Delivery Order SPE2DB22D1200-SPE2DB24FN4GR
Award Date
8/19/24
Potential Completion Date
8/20/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,061.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials. It is a firm-fixed-price delivery order with a completion date of February 3, 2025. The contract was not set aside for any specific business category. In addition to this contract, AmerisourceBergen holds a...
This federal contract award, valued at $8,386.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of M-M-R II vaccine vials, a childhood vaccine for measles, mumps, and rubella. This is a Firm Fixed Price delivery order contract with a period of performance through May 7, 2025. The contract is not set aside for any specific business type. Amerisourcebergen...
This federal contract award, valued at $4,874.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of M-M-R II Vaccine Vials, a vaccine used for the prevention of measles, mumps, and rubella. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999...
This federal contract award is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials to the Defense Logistics Agency (DLA). The $1,661.67 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 24, 2025 with an ultimate completion date of February 25, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of M-M-R II (measles, mumps, rubella) vaccine vials. The order has a ceiling value of $3,025.42 and a completion date of August 22, 2024. The contract is firm fixed price and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical products and supplies to support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of M-M-R II vaccine vials. The contract, valued at $36,245.43, is a Firm Fixed Price Delivery Order with a period of performance ending on September 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to supply the critical vaccine to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The...
This federal contract award, valued at $5,787.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor. The contract is for the delivery of M-M-R II vaccine vials, a vaccine used to prevent measles, mumps, and rubella. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 30, 2024. No set-aside designation was used for this award. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials. The contract has a firm fixed-price of $1,537.14 and an ultimate completion date of August 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of M-M-R II (Measles, Mumps, Rubella) vaccine vials. The Delivery Order, valued at $3,074.28, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is a component of the Department of Defense (DoD). The contract has a firm fixed-price pricing type and an ultimate completion date of May 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company,...
This federal contract award, valued at $1,763.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of M-M-R II VACCINE VIALS, with a completion date of March 27, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...